Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
47.55
-0.91 (-1.88%)
At close: Nov 18, 2025, 4:00 PM EST
47.28
-0.27 (-0.57%)
After-hours: Nov 18, 2025, 6:58 PM EST
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Jun 30, 2025 | 33.04B | 12.25B | 3.07B |
| Mar 31, 2025 | 32.83B | 11.25B | 2.93B |
| Dec 31, 2024 | 32.03B | 10.10B | 2.89B |
| Sep 30, 2024 | 30.72B | 8.52B | 2.71B |
| Jun 30, 2024 | 29.88B | 7.51B | 2.61B |
| Mar 31, 2024 | 28.29B | 6.95B | 2.63B |
| Dec 31, 2023 | 26.89B | 6.45B | 2.66B |
| Sep 30, 2023 | 24.99B | 5.56B | 2.70B |
| Jun 30, 2023 | 23.99B | 4.34B | 2.89B |
| Mar 31, 2023 | 22.83B | 3.30B | 3.06B |
| Dec 31, 2022 | 21.64B | 2.61B | 3.18B |
| Sep 30, 2022 | 20.61B | 2.15B | 3.16B |
| Jun 30, 2022 | 19.47B | 1.85B | 3.07B |
| Mar 31, 2022 | 18.48B | 1.59B | 3.04B |
| Dec 31, 2021 | 17.55B | 1.30B | 2.98B |
| Sep 30, 2021 | 16.38B | 1.11B | 2.94B |
| Jun 30, 2021 | 15.61B | 963.75M | 2.99B |
| Mar 31, 2021 | 15.30B | 878.47M | 2.96B |
| Dec 31, 2020 | 15.06B | 880.49M | 2.97B |
| Sep 30, 2020 | 15.59B | 937.23M | 3.10B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.